Actinobacteria and myxobacteria-two of the most important bacterial resources for novel antibiotics

Current Topics in Microbiology and Immunology

Volumn 398, Issue , 2016, Pages 273-302

  Landwehr, Wiebke ^a   Wolf, Corinna ^a   Wink, Joachim ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 HYDROXY 1 NORRESISTOMYCIN; 1,8 DIHYDROXY 2 ETHYL 3 METHYLANTHRAQUINONE; 2 ALLYLOXYPHENOL; ABYSSOMYCIN C; ALBIDOPYRONE; ANTIBIOTIC AGENT; ARENIMYCIN; AUREOVERTICILLACTAM; AVERMECTIN; BAFILOMYCIN; BISANTHRAQUINONE; CARBOXAMYCIN; CHLORAMPHENICOL; CINNABARAMIDE A; CINNABARAMIDE B; CINNABARAMIDE C; CINNABARAMIDE D; CINNABARAMIDE E; CINNABARAMIDE F; CINNABARAMIDE G; CYANOSPRASIDE A; CYCLOHEXIMIDE; CYCLOMARINE DERIVATIVE; ENTEROCIN; LINCOMYCIN; NALIDIXIC ACID; NYSTATIN; RIFAMPICIN; SALINISPORAMIDE B; UNCLASSIFIED DRUG; UNINDEXED DRUG; ANTIINFECTIVE AGENT;

ACTINOBACTERIA; ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM ISOLATION; DRUG STRUCTURE; GRAM NEGATIVE BACTERIUM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOREGULATION; MICROBIAL DIVERSITY; MICROMONOSPORACEAE; MYXOBACTERIA; NOCARDIOIDACEAE; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; PROTEOBACTERIA; PSEUDONOCARDIACEAE; SPECIES CULTIVATION; STREPTOMYCES; STREPTOMYCES VENEZUELAE; STREPTOMYCETACEAE; SYMBIOSIS; TAXONOMY; THERMOMONOSPORA; THERMOPHILIC BACTERIUM; TIME OF FLIGHT MASS SPECTROMETRY; CHEMISTRY; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MYXOCOCCALES;

ACTINOBACTERIA; ANTI-BACTERIAL AGENTS; MYXOCOCCALES;

EID: 85007410845     PISSN: 0070217X     EISSN: 21969965     Source Type: Book Series    
DOI: 10.1007/82_2016_503     Document Type: Article

References (167)

1. Abdel-Mageed WM, Milne BF, Wagner M, Schumacher M, Sandor P, Pathom-Aree W, Goodfellow M, Bull AT, Horikoshi K, Ebel R, Diederich M, Fiedler HP, Jaspars M (2010) Dermacozines, a new phenazine family from deep-sea dermacocci isolated from a Mariana Trench sediment. Org Biomol Chem 8:2352-2362.
2. Abdelmohsen UR, Pimentel-Elardo SM, Hanora A, Radwan M, Abou-El-Ela SH, Ahmed S, Hentschel U (2010) Isolation, phylogenetic analysis and anti-infective activity screening of marine sponge-associated actinomycetes. Mar Drugs 8:399-412.
3. Andersson M, Mikkola R, Kroppenstedt R, Rainey F, Peltola J, Helin J et al (1998) The mitochondrial toxin produced by Streptomyces griseus strains isolated from an indoor environment is valinomycin. Appl Environ Microbiol 64:4767-4773.
4. Arumugam M, Mitra A, Jaisankar P, Dasgupta S, Sen T, Gachhui R et al (2010) Isolation of an unusual metabolite 2-allyloxyphenol from a marine actinobacterium, its biological activities and applications. Appl Microbiol Biotechnol 86:109-117.
5. Asolkar RN, Jensen PR, Kauffman CA, Fenical W, Daryamides AC (2006) Weakly cytotoxic polyketides from a marine-derived actinomycete of the genus Streptomyces strain CNQ-085. J Nat Prod 69:1756-1759.
6. Baumann S, Herrmann J, Raju R, Steinmetz H, Mohr KI, Hüttel S, Harmrolfs K, Stadler M, Müller R (2014) Cystobactamids: myxobacterial topoisomerase inhibitors exhibiting potent antibacterial activity. Angew Chem Int Ed Engl 53:14605-14609.
7. Berod L, Friedrich C, Nandan A, Freitag J, Hagemann S, Harmrolfs K, Sandouk A, Hesse C, Castro CN, Bähre H, Tschirner SK, Gorinski N, Gohmert M, Mayer CT, Huehn J, Ponimaskin E, Abraham WR, Müller R, Lochner M, Sparwasser T (2014) De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat Med 20:1327-1333.
8. Bewick M, Williams S, Veltkamp C (1976) Growth and ultrastructure of Streptomyces venezuelae during chloramphenicol production. Microbios 16:191-199.
9. Bister B, Bischoff D, Ströbele M, Riedlinger J, Reicke A, Wolter F, Bull AT, Zähner H, Fiedler HP, Süssmuth RD (2004) Abyssomicin C-A-polycyclic antibiotic from a marine Verrucosispora strain as an inhibitor of the p-aminobenzoic acid/tetrahydrofolate biosynthesis pathway. Angew Chem Int Ed Engl 43:2574-2576.
10. Blunt JW, Copp BR, Hu WP, Munro MH, Northcote PT, Prinsep MR (2007) Marine natural products. Nat Prod Rep 24:31-86.
11. Blunt JW, Copp BR, Munro MHG, Northcote PT, Prinsep MR (2011) Marine natural products. Nat Prod Rep 28:196-268.
12. Blunt JW, Copp BR, Keyzers RA, Munro MHG, Prinsep MR (2012) Marine natural products. Nat Prod Rep 29:144-222.
13. Blunt JW, Copp BR, Keyzers RA, Munro MHG, Prinsep MR (2013) Marine natural products. Nat Prod Rep 30:237-323.
14. Brockman ER, Boyd WL (1963) Myxobacteria from soils of the Alaskan and Canadian Arctic. J Bacteriol 86:605-606.
15. Bruntner C, Binder T, Pathom-Aree W, Goodfellow M, Bull AT, Potterat O et al (2005) Frigocyclinone, a novel angucyclinone antibiotic produced by a Streptomyces griseus strain from Antarctica. J Antibiot 58:346-349.
16. Bull AT, Starch JEM (2007) Marine actinobacteria: new opportunities for natural product search and discovery. Trends in Microbiol 15:491-499.
17. Burg RW, Miller BM, Baker EE, Birnbaum J, Currie SA, Hartman R et al (1997) Avermectins, new family of potent anthelmintic agents: producing organism and fermentation. Antimicrob Agents Chemother 15:361-367.
18. Burger H, Foekens JA, Look MP, Meijer-van Gelder ME, Klijn JG, Wiemer EA, Stoter G, Nooter K (2003) RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response. Clin Cancer Res 9:827-836.
19. Carlson JC, Li S, Burr DA, Sherman DH (2009) Isolation and characterization of tirandamycins from a marine-derived Streptomyces sp. J Nat Prod 72:2076-2079.
20. Charan RD, Schlingmann G, Janso J, Bernan V, Feng X, Carter GT (2004) Diazepinomicin, a new antimicrobial alkaloid from a marine Micromonospora sp. J Nat Prod 67:1431-1433.
21. Chau R, Kalaitzis JA, Neilan BA (2011) On the origins and biosynthesis of tetrodotoxin. Aqua Toxicol 104:61-72.
22. Chauhan D, Catley L, Li G, Podar K, Hideshima T, Velankar M et al (2005) A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib. Cancer Cell 8:407-419.
23. Connor DT, Greenough RC, Strandtmann M (1977) W-7783, a unique antifungal antibiotic. J Org Chem 42:3664-3669.
24. Corominas-Faja B, Cuyàs E, Gumuzio J, Bosch-Barrera J, Leis O, Martin ÁG, Menendez JA (2014) Chemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cells. Oncotarget 5:8306-8316.
25. Dawid W (1978) Fruchtkörperbildene Myxobakterien in Böden Brasiliens. Z Allg Mikrobiol 34:333-335.
26. Dawid W, Gallikowski CA, Hirsch P (1988) 3.8 Psychrophilic myxobacteria from antarctic soils. Polarforschung 58:271-278 (Alfred Wegener Institute for Polar and Marine Research & German Society of Polar Research, Bremerhaven).
27. Demain A (1999) Pharmaceutically active secondary metabolites of microorganisms. Appl Microbiol Biotechnol 52:455-463.
28. Do H, Kogure K, Simidu U (1990) Identification of deep-sea-sediment bacteria which produce tetrodotoxin. Appl Environ Microbiol 56:1162.
29. Do H, Kogure K, Imada C, Noguchi T, Ohwada K, Simidu U (1991) Tetrodotoxin production of actinomycetes isolated from marine sediment. J Appl Microbiol 70:464-468.
30. Egan S, Wiener P, Kallifidas D, Wellington EMH (1998) Transfer of streptomycin biosynthesis gene clusters within streptomycetes isolated from soil. Appl Environ Microbiol 64:5061-5063.
31. Egerton N (2008) Ixabepilone (ixempra), a therapeutic option for locally advanced or metastatic breast cancer. P T 33:523-531.
32. El-Gendy MM, Shaaban M, Shaaban KA, El-Bondkly AM, Laatsch H (2008) Essramycin: a first triazolopyrimidine antibiotic isolated from nature. J Antibiot 61:149-157.
33. Engelhardt K, Degnes KF, Kemmler M, Bredholt H, Fjaervik E, Klinkenberg G, Sletta H, Ellingsen TE, Zotchev SB (2010) Production of a new thiopeptide antibiotic, TP-1161, by a marine Nocardiopsis species. Appl Environ Microbiol 76:4969-4976.
34. Fenical W, Jensen P (2006) Developing a new resource for drug discovery: marine actinomycete bacteria. Nature Chem Biol 2:666-673.
35. Fenical W, Baden D, Burg M, de Goyet CV, Grimes JD, Katz M, Marcus NH, Pomponi S, Rhines P, Tester P, Vena J (1999) Marine derived pharmaceuticals and related bioactive compounds. In: Fenical W (ed) From monsoons to microbes: understanding the ocean’s role in human health, National Academies Press, pp 71-86.
36. Fiedler HP, Bruntner C, Riedlinger J, Bull AT, Knutsen G, Goodfellow M, Jones A, Maldonado L, Pathom-Aree W, Beil W, Schneider K, Keller S, Sussmuth RD (2008) Proximicin A, B and C, novel aminofuran antibiotic and anticancer compounds isolated from marine strains of the actinomycete Verrucosispora. J Antibiot 61:158-163.
37. Frändberg E, Petersson C, Lundgren LN, Schnürer J (2000) Streptomyces halstedii K122 produces the antifungal compounds bafilomycin B1 and C1. Can J Microbiol 46:753-758.
38. Fujii I, Ebizuka Y (1997) Anthracycline biosynthesis in Streptomyces galilaeus. Chem Rev 97:2511-2524.
39. Gao X, Lu Y, Xing Y, Ma Y, Lu J, Bao W, Wang Y, Xi T (2012) A novel anticancer and antifungus phenazine derivative from a marine actinomycete BM-17. Microbiol Res 167:616622.
40. Garcia RO, Müller R (2014a) The family haliangiaceae. In: Rosenberg E, DeLong EF, Lory S, Stackebrandt E, Thompson F (eds) The prokaryotes deltaproteobacteria and epsilonproteobacteria, Springer, pp 173-181.
41. Garcia RO, Müller R (2014b) The family myxococcaceae. In: Rosenberg E, DeLong EF, Lory S, Stackebrandt E, Thompson F (eds) The prokaryotes deltaproteobacteria and epsilonproteobacteria, Springer, pp 192-212.
42. Garcia RO, Müller R (2014c) The family nannocystaceae. In: Rosenberg E, DeLong EF, Lory S, Stackebrandt E, Thompson F (eds) The prokaryotes deltaproteobacteria and epsilonproteobacteria, Springer, pp 213-229.
43. Garcia RO, Müller R (2014d) The family phaselicastaceae. In: Rosenberg E, DeLong EF, Lory S, Stackebrandt E, Thompson F (eds) The prokaryotes deltaproteobacteria and epsilonproteobacteria, Springer, pp 239-245.
44. Garcia RO, Müller R (2014e) The family polyangiaceae In: Rosenberg E, DeLong EF, Lory S, Stackebrandt E, Thompson F (eds) The prokaryotes deltaproteobacteria and epsilonproteobacteria, Springer, pp 247-279.
45. Garcia RO, Krug D, Müller R (2009) Discovering natural products from myxobacteria with emphasis on rare producer strains in combination with improved analytical methods. Methods Enzymol 458:59-91.
46. Garcia R, Pistorius D, Stadler M, Müller R (2011) Fatty acid-related phylogeny of myxobacteria as an approach to discover polyunsaturated omega-3/6 fatty acids. J Bacteriol 139:1930-1942.
47. Gemperlein K, Zipf G, Bernauer HS, Müller R, Wenzel SC (2016) Metabolic engineering of Pseudomonas putida for production of docosahexaenoic acid based on a myxobacterial PUFA synthase. Metab 33:98-108.
48. Gerth K, Irschik H, Reichenbach H, Trowitzsch W (1980) Myxothiazol, an antibiotic from Myxococcus fulvus (myxobacterales). I. Cultivation, isolation, physico-chemical and biological properties. J Antibiot 33:1474-1479 Tokyo.
49. Gerth K, Pradella S, Perlova O, Beyer S, Müller R (2003) Myxobacteria: proficient producers of novel natural products with various biological activities-past and future biotechnological aspects with the focus on the genus Sorangium. J Biotechnol 106:233-253.
50. Gerth K, Ischik H, Reichenbach H, Trowitzsch WPG (1982) The myxovirescins, a family of antibiotics from Myxococcus virescens (myxobacterales). J Antibiot 35:1454-1459.
51. Gerth K, Bedorf N, Irschik H, Höfle G, Reichenbach H (1994) The soraphens: a family of novel antifungal compounds from Sorangium cellulosum (Myxobacteria). I. Soraphen A1 alpha: fermentation, isolation, biological properties. J Antibiot 47:23-31.
52. Gerth K, Bedorf N, Irschik H, Höfle G, Reichenbach H (1996) Epothilons A and B: antifungal and cytotoxic compounds from Sorangium cellulosum (myxobacteria) production, physico-chemical and biological properties. J Antibiot 49:560-563.
53. Goldman BS, Nierman WC, Kaiser D, Slater SC, Durkin AS, Eisen JA, Ronning CM, Barbazuk WB, Blanchard M, Field C, Halling C, Hinkle G, Iartchuk O, Kim HS, Mackenzie C, Madupu R, Miller N, Shvartsbeyn A, Sullivan SA, Vaudin M, Wiegand R, Kaplan HB (2006) Evolution of sensory complexity recorded in a myxobacterial genome. Proc Natl Atlac Sci USA 103:15200-15205.
54. Goodfellow M, Haynes JA (1984) Actinomycetes in marine sediments. In: Ortiz-Ortiz L, Bojalil LF, Yakoleff V (eds) Biological, biochemical, and biomedical aspects of actinomycetes. Academic Press, New York, pp 453-472.
55. Gorajana A, Kurada BV, Peela S, Jangam P, Vinjamuri S, Poluri E et al (2005) 1-Hydroxy-1-norresistomycin, a new cytotoxic compound from a marine actinomycete, Streptomyces chibaensis AUBN1/7. J Antibiot 58:526-529.
56. Grabley S, Thiericke R (1999) The impact of natural products on drug discovery. Drug discovery from nature, Springer, pp 3-37.
57. Han SK, Nedashkovskaya OI, Mikhailov VV, Kim SB, Bae KS (2003) Salinibacterium amurskyense gen. nov., sp. nov., a novel genus of the family microbacteriaceae from the marine environment. Int J Syst Evol Microbiol 53:2061-2066.
58. Hansen LH, Ferrari B, Sørensen AH, Veal D, Sørensen S (2001) Detection of oxytetracycline production by Streptomyces rimosus in soil microcosmos by combining whole cell biosensors and flow cytometry. Appl Environ Microbiol 67:239-244.
59. Hawas UW, Shaaban M, Shaaban KA, Speitling M, Maier A, Kelter G, Fiebig HH, Meiners M, Helmke E, Laatsch H (2009) Mansouramycins A-D, cytotoxic isoquinolinequinones from a marine streptomycete. J Nat Prod 72:2120-2124.
60. Hayakawa Y, Shirasaki S, Shiba S, Kawasaki T, Matsuo Y, Adachi K et al (2007) Piericidins C7 and C8, new cytotoxic antibiotics produced by a marine Streptomyces sp. J Antibiot 60:196-200.
61. Helaly SE, Pesic A, Fiedler HP, Süßmuth RD (2011) Elaiomycins B and C: Alkylhydrazide antibiotics from Streptomyces sp. BK 190. Org Lett 13:1052-1055.
62. Helmke E, Weyland H (1984) Rhodococcus marinonascens sp. nov., an actinomycete from the sea. Int J Syst Bacteriol 34:127-138.
63. Hentschel U, Hopke J, Horn M, Friedrich AB, Wagner M, Hacker J, Moore BS (2002) Molecular evidence for a uniform microbial community in sponges from different oceans. Appl Environ Microbiol 68:4431-4440.
64. Hentschel U, Piel J, Degnan SM, Taylor MW (2012) Genomic insights into marine sponge microbiome. Nat Rev Microbiol 10:641-654.
65. Herr RR, Jahnke HK, Argoudelis AD (1967) Structure of streptozotocin. J Am Chem Soc 89:4808-4809.
66. Hill RT (2004) Microbes from marine sponges: a treasure trove of biodiversity for natural products discovery. In: Bull AT (ed) Microbial diversity and bioprospecting, ASM Press, pp. 225-231.
67. Hohmann C, Schneider K, Bruntner C, Brown R, Jones AL, Goodfellow M, Krämer M, Imhoff JF, Nicholson G, Fiedler HP, Süssmuth RD (2009a) Albidopyrone, a new alpha-pyrone-containing metabolite from marine-derived Streptomyces sp. NTK 227. J Antibiot 62:75-79.
68. Hohmann C, Schneider K, Bruntner C, Irran E, Nicholson G, Bull AT et al (2009b) Caboxamycin, a new antibiotic of the benzoxazole family produced by the deep-sea strain Streptomyces sp. NTK 937. J Antibiot 62:99-104.
69. Hook LA (1977) Distribution of myxobacters in aquatic habitats of an alkaline bog. Appl Environ Microbiol 34:333-335.
70. Huang YF, Tian L, Fu HW, Hua HM, Pei YH (2006) One new anthraquinone from marine Streptomyces sp. FX-58. Nat Prod Res 20:1207-1210.
71. Iizuka T, Jojima Y, Fudou R, Yamanaka S (1998) Isolation of myxobacteria from the marine environment. FEMS Microbiol Lett 169:317-322.
72. Inagaki F, Suzuki M, Takai K, Oida H, Sakamoto T, Aoki K, Nealson KH, Horikoshi K (2003) Microbial communities associated with geological horizons in coastal subseafloor sediments from the Sea of Okhotsk. Appl Environ Microbiol 69:7224-7235.
73. Irschik H, Reichenbach H (1985) The mechanism of action of myxovalargin A, a peptide antibiotic from Myxococcus fulvus. J Antibiot 38:1237-1245 Tokyo.
74. Irschik H, Gerth K, Kemmer T, Steinmetz H, Reichenbach H (1983) The myxovalargins, new peptide antibiotics from Myxococcus fulvus (Myxobacterales). I. Cultivation, isolation, and some chemical and biological properties. J Antibiot 36:6-12 Tokyo.
75. Irschik H, Jansen R, Gerth K, Höfle G, Reichenbach H (1987) The sorangicins, novel and powerful inhibitors of eubacterial RNA polymerase isolated from myxobacteria. J Antibiot 0:7-13 (Tokyo).
76. Irschik H, Augustiniak H, Gerth K, Höfle G, Reichenbach H (1995) The ripostatins, novel inhibitors of eubacterial RNA polymerase isolated from myxobacteria. J Antibiot 48:787-792 Tokyo.
77. Irschik H, Schummer D, Höfle G, Reichenbach H, Steinmetz H, Jansen R (2007) Etnangien, a macrolide-polyene antibiotic from Sorangium cellulosum that inhibits nucleic acid polymerases. J Nat Prod 70:1060-1063.
78. Jensen PR, Dwight R, Fenical W (1991) Distribution of actinomycetes in near-shore tropical marine sediments. Appl Environ Microbiol 57:1102-1108.
79. Jensen PR, Williams PG, Oh DC, Zeigler L, Fenical W (2007) Species-specific secondary metabolite production in marine actinomycetes of the genus Salinispora. Appl Environ Microbiol 73:1146-1152.
80. Jeong SY, Shin HJ, Kim TS, Lee HS, Park S, Kim HM (2006) Streptokordin, a new cytotoxic compound of the methylpyridine class from a marine-derived Streptomyces sp. KORDI-3238. J Antibiot 59:234-240.
81. Jiang S, Sun W, Chen M, Dai S, Zhang L, Liu Y, Lee KJ, Li X (2007) Diversity of culturable actinobacteria isolated from marine sponge Haliclona sp. Antonie Van Leeuwenhoek 92:405-416.
82. Jørgensen H, Degnes KF, Dikiy A, Fjaervik E, Klinkenberg G, Zotchev SB (2010) Insights into the evolution of macrolactam biosynthesis through cloning and comparative analysis of the biosynthetic gene cluster for a novel macrocyclic lactam, ML-449. Appl Environ Microbiol 76:283-293.
83. Kanoh K, Matsuo Y, Adachi K, Imagawa H, Nishizawa M, Shizuri Y (2005) Mechercharmycins A and B, cytotoxic substances from marine-derived Thermoactinomyces sp. YM3-251. J Antibiot 58:289-292.
84. Karwehl S, Stadler M (2016) Exploitation of fungal biodiversity for discovery of novel antibiotics. Curr Top Microbiol Immunol, in press (doi: 10.1007/82_2016_496).
85. Kim SB, Oh HM, Kang H, Park SS, Chun J (2004) Remarkable bacterial diversity in the tidal flat sediment as revealed by 16S rDNA analysis. J Microbiol Biotechnol 14:205-211.
86. Kock I, Maskey RP, Biabani MAF, Helmke E, Laatsch H (2005) 1-Hydroxy-1-norresistomycin and resistoflavin methyl ether: new antibiotics from marine-derived streptomycetes. J Antibiot 58:530-535.
87. Koutsoudakis G, Romero-Brey I, Berger C, Pérez-Vilaró G, Monteiro Perin P, Vondran FW, Kalesse M, Harmrolfs K, Müller R, Martinez JP, Pietschmann T, Bartenschlager R, Brönstrup M, Meyerhans A, Díez J (2015) Soraphen A: a broad-spectrum antiviral natural product with potent anti-hepatitis C virus activity. J Hepatol 63:813-821.
88. Kunze B, Kemmer T, Höfle G, Reichenbach H (1984) Stigmatellin, a new antibiotic from Stigmatella aurantiaca (Myxobacterales). I. Production, physico-chemical and biological properties. J Antibiot 37:454-461 Tokyo.
89. Kunze B, Höfle G, Reichenbach H (1987) The aurachins, new quinoline antibiotics from myxobacteria: production, physico-chemical and biological properties. J Antibiot 40:258-265 Tokyo.
90. Kunze B, Jansen R, Höfle G, Reichenbach H (1994) Crocacin, a new electron transport inhibitor from Chondromyces crocatus (myxobacteria). Production, isolation, physico-chemical and biological properties. J Antibiot 47:881-886 Tokyo.
91. Kunze B, Jansen R, Sasse F, Höfle G, Reichenbach H (1995) Chondramides A approximately D, new antifungal and cytostatic depsipeptides from Chondromyces crocatus (myxobacteria). Production, physico-chemical and biological properties. J Antibiot 48:1262-1266 Tokyo.
92. Kwon HC et al (2006) Marinomycins A-D, antitumor-antibiotics of a new structure class from a marine actinomycete of the recently discovered genus ‘‘Marinospora’’. J Am Chem Soc 128:1622-1632.
93. Lam KS (2006) Discovery of novel metabolites from marine actinomycetes. Curr Opin Microbiol 9:245-251.
94. Li DH, Zhu TJ, Liu HB, Fang YC, Gu QQ, Zhu WM (2006) Four butenolides are novel cytotoxic compounds isolated from the marine-derived bacterium, Streptoverticillium luteoverticillatum 11014. Arch Pharmacal Res 29:624-626.
95. Li F, Maskey RP, Qin S, Sattler I, Fiebig HH, Maier A et al (2005) Chinikomycins A and B: isolation structure elucidation, and biological activity of novel antibiotics from a marine Streptomyces sp. isolate M045. J Nat Prod 68:349-353.
96. Link HF (1809) Observations in Ordines plantarum naturales. Dissertatio prima, complectens Anandrarum ordines Epiphytas, Mucedines Gastomycos et Fungos. Der Geselllschaft Naturforschender Freunde zu Berlin Magazin für die neuesten Entdeckungen in der gesamten Naturkunde 3:1-42.
97. Lu J, Ma Y, Liang J, Xing Y, Xi T, Lu Y (2012) Aureolic acids from a marine-derived Streptomyces sp. WBF16. Microbiol Res 167:590-595.
98. Macherla VR, Liu J, Bellows C, Teisan S, Nicholson B, Lam KS et al (2005) Glaciapyrroles A, B and C, pyrrolosesquiterpenes from a Streptomyces sp. isolated from an Alaskan marine sediment. J Nat Prod 68:780-783.
99. Magarvey NA, Keller JM, Bernan V, Dworkin M, Sherman DH (2004) Isolation and characterization of novel marine-derived actinomycete taxa rich in bioactive metabolites. Appl Environ Microbiol 70:7520-7529.
100. Maldonado LA, Fenical W, Jensen PR, Kauffman CA, Mincer TJ, Bull AT, Ward AC, Goodfellow M (2005a) Salinispora arenicola gen. nov., sp nov and Salinispora tropica sp nov., obligate marine actinomycetes belonging to the family micromonosporaceae. Int J Syst Evol Microbiol 55:1759-1766.
101. Maldonado LA, Starch JEM, Pathom-Aree W, Ward AC, Bill AT, Goodfellow M (2005b) The diversity of cultivable actinobacteria in geographically widespread marine sediments. Antonie Van Leeuwenhoek 87:11-18.
102. Manam RR, Teisan S, White DJ, Nishino T, Grodberg J, Neuteboom STC et al (2005) Lajollamycin, a nitro-tetraene spiro-b-lactone-g-lactam antibiotic from the marine actinomycete Streptomyces nodosus. J Nat Prod 68:240-243.
103. Mao Y, Varoglu M, Sherman DH (1999) Molecular characterization and analysis of the biosynthetic gene cluster for the antitumor antibiotic mitomycin C from Streptomyces lavendulae NRRL 2564. Chem Biol 6:251-263.
104. Martinez JP, Hinkelmann B, Fleta-Soriano E, Steinmetz H, Jansen R, Diez J, Frank R, Sasse F, Meyerhans A (2013) Identification of myxobacteria-derived HIV inhibitors by a high-throughput two-step infectivity assay. Microb Cell Fact 12:85.
105. Manivasagan P, Venkatesan J, Sivakumar K, Kim S-K (2013) Marine actinobacterial metabolites: Current status and future perspectives. Microbiol Res 168:311-332.
106. Mantalvo NF, Mohamed NM, Enticknap JJ, Hill RT (2005) Novel actinobacteria from marine sponges. Antonie Van Leeuwenhoek 87:29-36.
107. McArthur KA, Mitchell SS, Tsueng G, Rheingold A, White DJ, Grodberg J, Lam KS, Potts BC (2008) Lynamicins A-E, chlorinated bisindole pyrrole antibiotics from a novel marine actinomycete. J Nat Prod 71:1732-1737.
108. Mincer TJ, Jensen PR, Kauffman CA, Fenical W (2002) Widespread and persistent populations of a major new marine actinomycete taxon in ocean sediments. Appl Environ Microbiol 68:5005-5011.
109. Mincer TJ, Fenical W, Jensen PR (2005) Culture-dependent and culture-independent diversity within the obligate marine actinomycete genus Salinispora. Appl Environ Microbiol 71:70197028.
110. Mitchell SS, Nicholson B, Teisan S, Lam KS, Potts BC (2004) Aureoverticillactam, a novel 22-atom macrocyclic lactam from the marine actinomycete Streptomyces aureoverticillatus. J Nat Prod 67:1400-1402.
111. Mohr KI, Stechling M, Wink J, Wilharm E, Stadler M (2015) Comparison of myxobacterial diversity and evaluation of isolation success in two niches: Kiritimati Island and German compost. Microbiologyopen 5:268-278.
112. Moore BS, Trischman JA, Seng D, Kho D, Jensen PR, Fenical W (1999) Salinamides, antiinflammatory depsipeptides from a marine streptomycete. J Org Chem 64:1145-1150.
113. Moore BS, Kalaitzis JA, Xiang L (2005) Exploiting marine actinomycete biosynthetic pathways for drug discovery. Antonie Van Leeuwenhoek 87:49-57.
114. Müller R, Wink J (2014) Future potential for anti-infectives from bacteria—how to exploit biodiversity and genomic potential. Int J Med Microbiol 304:3-13.
115. Oh DC, Gontang EA, Kauffman CA, Jensen PR, Fenical W (2008) Salinipyrones and pacificanones, mixed-precursor polyketides from the marine actinomycete salinispora pacifica. J Nat Prod 71:570-575.
116. Ojika M, Suzuki Y, Tsukamoto A, Sakagami Y, Fudou R, Yoshimura T, Yamanaka S (1998) Cystothiazoles A and B, new bithiazole-type antibiotics from the myxobacterium Cystobacter fuscus. J Antibiot 51:275-281 Tokyo.
117. Okami Y, Okazaki T (1972) Studies on marine microorganisms. J Antibiot 25:456-460.
118. Omura S, Nakagawa A, Fujimoto T, Saito K, Otoguro K, Walsh JC et al (1987) Hygromycin A, an antitreponemal substance. I. Screening method and therapeutic effect for Treponema hyodysenteriae-caused infection in CF-1 mice. J Antibiot 40:1619.
119. Oxford AE (1947) Observations concerning the growth and metabolic activities of myxococci in a simple protein-free liquid medium. J Bacteriol 53:129-138.
120. Papineau D, Walker JJ, Mojzsis SJ, Pace NR (2005) Composition and structure of microbial communities from stromatolites of Hamelin Pool in Shark Bay, Western Australia. Appl Environ Microbiol 71:4822-4832.
121. Pathom-Aree W, Stach JEM, Ward AC, Horikoshi K, Bull AT, Goodfellow M (2006) Diversity of actinomycetes isolated from challenger deep sediment (10,898 m) from the Mariana Trench. Extremophiles 10:181-189.
122. Perez Baz J, Cañedo LM, Fernández Puentes JL, Silva Elipe MV (1997) Thiocoraline, a novel depsipeptide with antitumor activity produced by a marine Micromonospora. II. Physico-chemical properties and structure determination. J Antibiot 50:738-741.
123. Peschke U, Schmidt H, Zhang HZ, Piepersberg W (2006) Molecular characterization of the lincomycin-production gene cluster of Streptomyces lincolnensis 78-11. Mol Microbiol 16:1137-1156.
124. Piel J, Hertweck C, Shipley PR, Hunt DM, Newman MS, Moore BS (2000) Cloning, sequencing and analysis of the enterocin biosynthesis gene cluster from the marine isolate ‘Streptomyces maritimus’: evidence for the derailment of an aromatic polyketide synthase. Chem Biol 7:943-955.
125. Pivot X, Dufresne A, Villanueva C (2007) Efficacy and safety of ixabepilone, a novel epothilone analogue. Clin Breast Canc 7:543-549.
126. Prudhomme J, McDaniel E, Ponts N, Bertani S, Fenical W, Jensen P et al (2008) Marine actinomycetes: a new source of compounds against the human malaria parasite. PLoS ONE 3:2335.
127. Rachid S, Huo L, Herrmann J, Stadler M, Köpcke B, Bitzer J, Müller R (2011) Mining the cinnabaramide biosynthetic pathway to generate novel proteasome inhibitors. ChemBioChem 12:922-931.
128. Reichenbach H (1983) A simple method for the purification of myxobacteria. J Microbiol Methods 1:77-79.
129. Reichenbach H, Höfle G (1993) Biologically active secondary metabolites from myxobacteria. Biotech Adv 11:219-277.
130. Reichenbach H, Gerth K, Irschik H, Kunze B, Höfle G (1988) Myxobacteria: a source of new antibiotics. Trends Biotechnol 6:115-121.
131. Reichenbach H, Lang E, Schumann P, Spröer C (2006a) Byssovorax cruenta gen. nov., sp. nov., nom. rev., an cellulose-degrading myxobacterium: rediscovery of ‘Myxococcus cruentus’ Thaxter 1897. Int J Syst Evol Microbiol 56:2357-2363.
132. Reichenbach H, Dworkin M, Shimkets LJ (2006) The myxobacteria In: Dworkin M, Falkow S, Rosenberg E, Schleifer K.-H. Stackebrandt E (eds) The prokaryotes, Springer, Berlin, vol 7, pp. 31-115.
133. Reichenbach H, Höfle G (2008) Discovery and development of the epothilones: a novel class of antineoplastic drugs. Drugs R D 9:1-10.
134. Ringel SM, Greenough RC, Roemer S (1977) Ambruticin (W7783), a new antifungal antibiotic. J Antibiot 30:371-375.
135. Saleh EA, Mahmoud SAZ, El-Haddad ME, Abdel-Fatah MK (1985) Purification and identification of Streptomyces aureofaciens ID13 antibiotic. Zentralblatt für Mikrobiologie 140:325-332.
136. Sanford RA, Cole JR, Tiedje JM (2002) Characterization and description of Anaeromyxobacter dehalogenans gen. nov., sp. nov., an aryl-halorespiring facultative anaerobic myxobacterium. Appl Environ Microbiol 68:893-900.
137. Sasse F, Steinmetz H, Höfle G, Reichenbach H (1993) Rhizopodin, a new compound from Myxococcus stipitatus (myxobacteria) causes formation of rhizopodia-like structures in animal cell cultures. Production, isolation, physico-chemical and biological properties. J Antibiot 46:741-748.
138. Sasse F, Böhlendorf B, Herrmann M, Kunze B, Forche E, Steinmetz H, Höfle G, Reichenbach H (1999) Melithiazols, new beta-methoxyacrylate inhibitors of the respiratory chain isolated from myxobacteria. Production, isolation, physico-chemical and biological properties. J Antibiot 52:721-729.
139. Selvin J, Joseph S, Asha KRT, Manjusha WA, Sangeetha VS, Jayaseema DM, Antony MC, Denslin Vinitha AJ (2004) Antibacterial potential of antagonistic Streptomyces sp. isolated from marine sponge Dendrilla nigra. FEMS Microbiol Ecol 50:117-122.
140. Schneiker S, Perlova O, Kaiser O, Gerth K, Alici A, Altmeyer MO, Bartels D, Bekel T, Beyer S, Bode E, Bode HB, Bolten CJ, Choudhuri JV, Doss S, Elnakady YA, Frank B, Gaigalat L, Goesmann A, Groeger C, Gross F, Jelsbak L, Jelsbak L, Kalinowski J, Kegler C, Knauber T, Konietzny S, Kopp M, Krause L, Krug D, Linke B, Mahmud T, Martinez-Arias R, McHardy AC, Merai M, Meyer F, Mormann S, Muñoz-Dorado J, Perez J, Pradella S, Rachid S, Raddatz G, Rosenau F, Rückert C, Sasse F, Scharfe M, Schuster SC, Suen G, Treuner-Lange A, Velicer GJ, Vorhölter FJ, Weissman KJ, Welch RD, Wenzel SC, Whitworth DE, Wilhelm S, Wittmann C, Blöcker H, Pühler A, Müller R (2007) Complete genome sequence of the myxobacterium Sorangium cellulosum. Nat Biotechnol 25:1281-1289.
141. Schreurs M, Van Dijk TH, Gerding A, Havinga R, Reijngoud DJ, Kuipers F (2009) Soraphen, an inhibitor of the acetyl-CoA carboxylase system, improves peripheral insulin sensitivity in mice fed a high-fat diet. Diabetes Obes Metab 11:987-991.
142. Schultz AW, Oh DC, Carney JR, Williamson RT, Udwary DW, Jensen PR, Gould SJ, Fenical W, Moore BS (2008) Biosynthesis and structures of cyclomarins and cyclomarazines, prenylated cyclic peptides of marine actinobacterial origin. J Am Chem Soc 130:4507-4516.
143. Shimkets LJ, Dworkin M, Reichbach H (2004) The myxobacteria, 3rd edn. Springer, New York.
144. Sivakumar K, Sahu MK, Thangaradjou T, Kannan L (2007) Research on marine actinobacteria in India. Ind J Microbiol 47:186-196.
145. Socha AM, LaPlante KL, Rowley DC (2006) New bisanthraquinone antibiotics and semisynthetic derivatives with potent activity against clinical Staphylococcus aureus and Enterococcus faecium isolates. Bioorganic Med Chem 14:8446-8454.
146. Soria-Mercado IE, Prieto-Davo A, Jensen PR, Fenical W (2005) Antibiotic terpenoid chloro-dihydroquinones from a new marine actinomycete. J Nat Prod 68:904-910.
147. Stach JEM, Bull AT (2005) Estimating and comparing the diversity of marine actinobacteria. Antonie Van Leeuwenhoek 87:3-9.
148. Stach JEM, Maldonado LA, Masson DG, Ward AC, Goodfellow M, Bull AT (2003) Statistical approaches to estimating bacterial diversity in marine sediments. Appl Environ Microbiol 69:6189-6200.
149. Stadler M, Bitzer J, Mayer-Bartschmid A, Müller H, Benet-Buchholz J, Gantner F, Tichy HV, Reinemer P, Bacon KB (2007) Cinnabaramides A-G: analogues of lactacystin and salinosporamide from a terrestrial streptomycete. J Nat Prod 70:246-252.
150. Steinert G, Whitfield S, Taylor MW, Thoms C, Schupp PJ (2014) Application of diffusion growth chambers for the cultivation of marine sponge-associated bacteria. Mar Biotechnol 16:594-603 Springer.
151. Surup F, Viehrig K, Mohr KI, Herrmann J, Jansen R, Müller R (2014) Disciformycins A and B: 12-membered macrolide glycoside antibiotics from the myxobacterium Pyxidicoccus fallax active against multiresistant staphylococci. Angew Chem Int Ed 53:13588-13591.
152. Takami H, Inoue A, Fuji F, Horikoshi K (1997) Microbial flora in the deepest sea mud of the Mariana Trench. FEMS Microbiol Lett 152:279-285.
153. Takizawa M, Colwell RR, Hill RT (1993) Isolation and diversity of actinomycetes in the Chesapeake Bay. Appl Environm Micobiol 59:997-1002.
154. Taylor and Francis Group (2016) Dictionary of natural products (online).
155. Thaxter R (1892) On the myxobacteriaceae, a new order of schizomycetes. Bot Gaz 17:389-406.
156. Uyeda M, Mizukami M, Yokomizo K, Suzuki K, Pentalenolactone I (2001) Hygromycin A. immunosuppressants produced by Streptomyces filipinensis and Streptomyces hygroscopicus. Biosci Biotechnol Biochem 65:1252-1254.
157. Vetcher L, Menzella HG, Kudo T, Motoyama T, Katz L (2013) The antifungal polyketide ambruticin targets the HOG pathway. Antimicrob Agents Chemother 51:3734-3736.
158. Vezina C, Kudelski A, Sehgal S (1975) Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J Antibiot 28:721-726.
159. Ward AC, Bora N (2006) Diversity and biogeography of marine actinobacteria. Curr Opin Microbiol 9:279-286.
160. Webster NS, Hill RT (2001) The culturable microbial community of the great barrier reef sponge Rhopaloeides odorabile. Appl Environ Microbiol 138:843-851.
161. Webster NS, Taylor MW (2012) Marine sponges and their microbial symbionts: love and other relationships. Environ Microbiol 14:335-346.
162. Weissmann KJ, Müller R (2009) A brief tour of myxobacterial secondary metabolism. Bioorg Med Chem 17:2121-2136.
163. Wenzel SC, Müller R (2009) The impact of genomics on the exploitation of the myxobacterial secondary metabolome. Nat Prod Rep 26:1385-1407.
164. Werner G, Hagenmaier H, Drautz H, Baumgartner A, Zähner H (1984) Metabolic products of microorganisms. bafilomycins, a new group of macrolide antibiotics. Production, isolation, chemical structure and biological activity. J Antibiot 37:110-117.
165. Williams PG, Buchanan GO, Feling RH, Kauffman CA, Jensen PR, Fenical W (2005) New cytotoxic Salinosporamides from the marine actinomycete Salinispora tropica. J Org Chem 70:6196-6203.
166. Wu SJ, Fotso S, Li F, Qin S, Kelter T, Fiebig HH et al (2006) 39-N-carboxamidostaurosporine and selina-4(14),7(11)-diene-8,9-diol, new metabolites from a marine Streptomyces sp. J Antibiot 59:331-337.
167. Wu Z, Xie L, Xia G, Zhang J, Nie Y, Hu J, Wang S, Zhang R (2005) A new tetrodotoxin-producing actinomycete, Nocardiopsis dassonvillei, isolated from the ovaries of pufferfish Fugu rubripes. Taxoicon 45:851-859.